Trial intelligence / Profile preview

Ritanserin in Treatment of Cocaine Dependence

NCT00000187Phase 2Completed

Sponsor
University of Pennsylvania
Start
Jul 1992
Primary completion
Jun 1994
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of ritanserin in cocaine dependence, sponsored by University of Pennsylvania. Primary endpoints: Cocaine use and Cocaine craving. Started Jul 1992; status: completed.

02

Drugs

ritanserin
03

Conditions

cocaine dependence

Beyond the preview

Go deeper on NCT00000187.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00000187.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call